Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eduard Grebe

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Plos One|April 12, 2018
Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for eliminationShelley N Facente, Eduard Grebe, Katie Burk, et al.
Plos One|July 27, 2019
Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillanceJoseph B Sempa, Alex Welte, Michael P Busch, et al.
Plos One|July 13, 2018
Correction: Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for eliminationShelley N Facente, Eduard Grebe, Katie Burk, et al.
Transfusion|July 10, 2024
SARS-CoV-2 antibody levels and long COVID occurrence in blood donorsVivian I Avelino-Silva, Roberta Bruhn, Karla G Zurita, et al.
Open Forum Infectious Diseases|July 12, 2024
HIV Subtypes and Drug-resistance-associated Mutations in US Blood Donors, 2015-2020Brian Custer, Eda Altan, Leilani Montalvo, et al.
Journal of Virological Methods|April 24, 2018
Development of antibody biomarkers of long term and recent dengue virus infectionsEduardo J M Nascimento, James W Huleatt, Marli T Cordeiro, et al.
Clinical Pharmacology and Therapeutics|December 23, 2022
Facilitating Next-Generation Pre-Exposure Prophylaxis Clinical Trials Using HIV Recent Infection Assays: A Consensus Statement from the Forum HIV Prevention Trial Design ProjectNeil Parkin, Fei Gao, Eduard Grebe, et al.
The Journal of Infectious Diseases|August 3, 2022
Coronavirus Disease 2019 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the United States Before the Delta- and Omicron-Associated Surges: A Retrospective Cohort Study of Repeat Blood DonorsEduard Grebe, Elaine A Yu, Marjorie D Bravo, et al.
Plos One|September 17, 2019
Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assaySheila M Keating, Wes Rountree, Eduard Grebe, et al.
Research Square|June 6, 2022
Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in South Africa in March 2022Jeremy Bingham, Russel Cable, Charl Coleman, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Plos One|April 12, 2018
Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for eliminationShelley N Facente, Eduard Grebe, Katie Burk, et al.
Plos One|July 27, 2019
Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillanceJoseph B Sempa, Alex Welte, Michael P Busch, et al.
Plos One|July 13, 2018
Correction: Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for eliminationShelley N Facente, Eduard Grebe, Katie Burk, et al.
Transfusion|July 10, 2024
SARS-CoV-2 antibody levels and long COVID occurrence in blood donorsVivian I Avelino-Silva, Roberta Bruhn, Karla G Zurita, et al.
Open Forum Infectious Diseases|July 12, 2024
HIV Subtypes and Drug-resistance-associated Mutations in US Blood Donors, 2015-2020Brian Custer, Eda Altan, Leilani Montalvo, et al.
Journal of Virological Methods|April 24, 2018
Development of antibody biomarkers of long term and recent dengue virus infectionsEduardo J M Nascimento, James W Huleatt, Marli T Cordeiro, et al.
Clinical Pharmacology and Therapeutics|December 23, 2022
Facilitating Next-Generation Pre-Exposure Prophylaxis Clinical Trials Using HIV Recent Infection Assays: A Consensus Statement from the Forum HIV Prevention Trial Design ProjectNeil Parkin, Fei Gao, Eduard Grebe, et al.
The Journal of Infectious Diseases|August 3, 2022
Coronavirus Disease 2019 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the United States Before the Delta- and Omicron-Associated Surges: A Retrospective Cohort Study of Repeat Blood DonorsEduard Grebe, Elaine A Yu, Marjorie D Bravo, et al.
Plos One|September 17, 2019
Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assaySheila M Keating, Wes Rountree, Eduard Grebe, et al.
Research Square|June 6, 2022
Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in South Africa in March 2022Jeremy Bingham, Russel Cable, Charl Coleman, et al.
Pageof 8